Search

This factsheet discusses HPV and related cancers, use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines.

In this Monitor, we explore how ongoing misinformation about the safety and efficacy of COVID-19 vaccines may affect the acceptance of new vaccine recommendations. First, we examine the false and misleading claims underlying the Kansas Attorney General’s lawsuit against Pfizer. We also discuss the CDC’s most recent vaccine.

vaccination, immunization, vaccination requirements, immunization requirements, child

This analysis examines the latest trends in children’s routine vaccination rates, including the various contributing factors and policies affecting rates. As of the 2022-2023 school year, the share of kindergarten children up to date on their state-required vaccinations has not rebounded to pre-pandemic levels.

This fact sheet examines Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in lower income countries, and explores the role the U.S. government plays in supporting the partnership.

In this issue, we take a closer look at the reliability of artificial intelligence (AI) chatbots as a source of health information. We explore public opinion on chatbot accuracy based on KFF surveys and highlight recent examples of AI-generated election misinformation in the news. In addition, we share our firsthand experience querying AI chatbots on health topics and discuss research on gaps in safeguards.

This edition focuses on intentionally false or misleading information online and its potential impact on public trust in health care. We share a recent report that exposed a covert U.S. military social media disinformation campaign in the Philippines that may have undermined public confidence in vaccines. We also examine how false claims about sunscreen and non-FDA-approved “miracle cures” may be discouraging people from taking important preventative measures and seeking legitimate medical treatment. Finally, we explore the rise of counterfeit diabetes and weight-loss drugs like Ozempic and the potential impact on trust in the pharmaceutical supply chain.

In his latest column, KFF President and CEO Drew Altman discusses the difficulties of navigating the misinformation minefield, including the ways in which the news media can amplify or confront misinformation.